- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.09. | Merck KGaA names new R&D chief for healthcare business | ||
| 03.09. | MSD, Ionis trumpet lipid-lowering drug data | ||
| 03.09. | A vaccine adcomm expert criticised RFK Jr - now he's out | ||
| 02.09. | 'Brainwave' test raises hopes of early dementia diagnosis | ||
| 02.09. | Ex-CDC chiefs sound alarm bells over HHS under Kennedy | ||
| 02.09. | OMass attracts $420m Roche wager on IBD programme | ||
| 02.09. | Uni wins big NIHR grant for healthtech 'horizon scanning' | ||
| 01.09. | ESC: MSD/Bayer's Verquvo disappoints in heart failure trial | ||
| 01.09. | IPO plan evaporates as private equity firm buys Stada | ||
| 01.09. | ESC: Real-world study gives Wegovy edge over Lilly rival | ||
| 01.09. | Sanofi breaks new ground for BTK drugs with ITP approval | ||
| 01.09. | ESC: 'Landmark' study backs AZ's baxdrostat for hypertension | ||
| 01.09. | Dose-at-home Leqembi for Alzheimer's cleared in US | ||
| 29.08. | Trump appoints HHS deputy O'Neill to lead CDC | ||
| 29.08. | UK adds chickenpox to childhood vaccination schedule | ||
| 28.08. | Outlook blindsided as FDA blocks wet AMD drug once again | ||
| 28.08. | Novo reels in Replicate for new cardiometabolic drugs | ||
| 28.08. | Scoop: Lumos Labs has FDA nod for ADHD DtX Prismira | ||
| 28.08. | Lilly pauses Mounjaro shipments to UK ahead of price hike | ||
| 28.08. | Stada revives talk of an IPO - if conditions improve | ||
| 28.08. | Lilly raises stakes in Novartis battle with Verzenio data | ||
| 28.08. | CDC director refuses to step down after being fired | ||
| 27.08. | FDA ends emergency COVID authorisations, issues narrow approvals | ||
| 27.08. | Survey reveals 'trust gap' in the value of AI to cardiology | ||
| 27.08. | ESC: Study says GLP-1s treat heart failure AND cut emissions |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .